Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tocilizumab for Cytokine Release Syndrome Prophylaxis in Peripheral Blood Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide

NCT03533101 is registered in ClinicalTrials.gov with Hospital Universitario Dr. Jose E. Gonzalez as lead sponsor.

NCT NCT03533101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03533101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tocilizumab for Cytokine Release Syndrome Prophylaxis in Peripheral Blood Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide
Lead sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Phase
Phase 1/2
Overall status
Completed
Start date
May 25, 2018
Completion date
June 15, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytokine release syndrome, stem cell transplant complications